{"id":"https://openalex.org/W2002608073","doi":"https://doi.org/10.1016/j.bmcl.2008.07.088","title":"Structure\u2013activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350","display_name":"Structure\u2013activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350","publication_year":2008,"publication_date":"2008-07-25","ids":{"openalex":"https://openalex.org/W2002608073","doi":"https://doi.org/10.1016/j.bmcl.2008.07.088","mag":"2002608073","pmid":"https://pubmed.ncbi.nlm.nih.gov/18678486"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2008.07.088","doi":"https://doi.org/10.1016/j.bmcl.2008.07.088","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2008.07.088","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043951728","display_name":"Pierre Raboisson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Pierre Raboisson","raw_affiliation_strings":["Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088780090","display_name":"Herman de Kock","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Herman de Kock","raw_affiliation_strings":["Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002491926","display_name":"\u00c5sa Rosenquist","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"\u00c5sa Rosenquist","raw_affiliation_strings":["Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Magnus Nilsson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Magnus Nilsson","raw_affiliation_strings":["Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058402400","display_name":"Lourdes Salvador Oden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Lourdes Salvador-Oden","raw_affiliation_strings":["Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003454997","display_name":"Tse\u2010I Lin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tse-I Lin","raw_affiliation_strings":["Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026524539","display_name":"Natalie Roue","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Natalie Roue","raw_affiliation_strings":["Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Vladimir Ivanov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Vladimir Ivanov","raw_affiliation_strings":["Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055319537","display_name":"Horst W\u00e4hling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Horst W\u00e4hling","raw_affiliation_strings":["Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005672427","display_name":"Kristina Wickstr\u00f6m","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Kristina Wickstr\u00f6m","raw_affiliation_strings":["Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078930676","display_name":"Elizabeth Hamelink","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Elizabeth Hamelink","raw_affiliation_strings":["Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110137214","display_name":"Michael Edlund","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Michael Edlund","raw_affiliation_strings":["Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086480661","display_name":"Lotta Vrang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Lotta Vrang","raw_affiliation_strings":["Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041362155","display_name":"Sandrine Vendeville","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandrine Vendeville","raw_affiliation_strings":["Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087194116","display_name":"Wim Van de Vreken","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wim Van de Vreken","raw_affiliation_strings":["Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042514086","display_name":"David C. McGowan","orcid":"https://orcid.org/0000-0002-3759-6771","observed_orcids":["https://orcid.org/0000-0002-3759-6771"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David McGowan","raw_affiliation_strings":["Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108490622","display_name":"Abdellah Tahri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abdellah Tahri","raw_affiliation_strings":["Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029714317","display_name":"Lili Hu","orcid":"https://orcid.org/0000-0001-8370-3331","observed_orcids":["https://orcid.org/0000-0001-8370-3331"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lili Hu","raw_affiliation_strings":["Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045270341","display_name":"Carlo Boutton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carlo Boutton","raw_affiliation_strings":["Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031660163","display_name":"Oliver Lenz","orcid":"https://orcid.org/0009-0006-4942-6557","observed_orcids":["https://orcid.org/0009-0006-4942-6557"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oliver Lenz","raw_affiliation_strings":["Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038410296","display_name":"Fr\u00e9d\u00e9ric Delouvroy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frederic Delouvroy","raw_affiliation_strings":["Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048501169","display_name":"Geert M. E. Pille","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Geert Pille","raw_affiliation_strings":["Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015605071","display_name":"Dominique L. N. G. Surleraux","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dominique Surleraux","raw_affiliation_strings":["Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052273030","display_name":"Piet B. T. P. Wigerinck","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Piet Wigerinck","raw_affiliation_strings":["Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112790292","display_name":"Bertil Samuelsson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Bertil Samuelsson","raw_affiliation_strings":["Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir AB, PO Box 1086, SE-141 22 Huddinge, Sweden","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027321246","display_name":"Kenneth Simmen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenneth Simmen","raw_affiliation_strings":["Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Gen. De Wittelaan L11 B3, B-2800 Mechelen, Belgium & Tibotec Pharmaceuticals Ltd, Eastgate Village, EastGate, Little Island, Co Cork, Ireland","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5043951728"],"corresponding_institution_ids":[],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":10.6423,"has_fulltext":false,"cited_by_count":146,"citation_normalized_percentile":{"value":0.98455549,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"18","issue":"17","first_page":"4853","last_page":"4858"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatitis-c-virus","display_name":"hepatitis C virus","score":0.8029999732971191},{"id":"https://openalex.org/keywords/ns3-4a-protease","display_name":"NS3/4A protease","score":0.9869999885559082},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.9079999923706055},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.8569999933242798},{"id":"https://openalex.org/keywords/quinoline-derivatives","display_name":"quinoline derivatives","score":0.7080000042915344},{"id":"https://openalex.org/keywords/thiazole","display_name":"thiazole","score":0.6980000138282776},{"id":"https://openalex.org/keywords/antiviral-agents","display_name":"antiviral agents","score":0.5960000157356262},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7580000162124634},{"id":"https://openalex.org/keywords/viral-replication-inhibition","display_name":"viral replication inhibition","score":0.4620000123977661}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8611650466918945},{"id":"https://openalex.org/C132379496","wikidata":"https://www.wikidata.org/wiki/Q83141645","display_name":"NS3","level":4,"score":0.7980684638023376},{"id":"https://openalex.org/C2778556512","wikidata":"https://www.wikidata.org/wiki/Q80260","display_name":"Cyclopentane","level":2,"score":0.6789829134941101},{"id":"https://openalex.org/C18103114","wikidata":"https://www.wikidata.org/wiki/Q1720369","display_name":"Replicon","level":4,"score":0.6446409225463867},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.6056519150733948},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.6019518971443176},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.5504414439201355},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4953369200229645},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.46768954396247864},{"id":"https://openalex.org/C2781039511","wikidata":"https://www.wikidata.org/wiki/Q3208529","display_name":"Sulfonamide","level":2,"score":0.46236613392829895},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.4502026438713074},{"id":"https://openalex.org/C140704245","wikidata":"https://www.wikidata.org/wiki/Q3933202","display_name":"Viral replication","level":3,"score":0.41325193643569946},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.39183947443962097},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3742976486682892},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.2675408124923706},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2466500997543335},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08230236172676086},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C22744801","wikidata":"https://www.wikidata.org/wiki/Q172778","display_name":"Plasmid","level":3,"score":0.0},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069616","descriptor_name":"Simeprevir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000085242","descriptor_name":"Viral Proteases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003517","descriptor_name":"Cyclopentanes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003517","descriptor_name":"Cyclopentanes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006575","descriptor_name":"Heterocyclic Compounds, 3-Ring","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006575","descriptor_name":"Heterocyclic Compounds, 3-Ring","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012697","descriptor_name":"Serine Endopeptidases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014764","descriptor_name":"Viral Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017361","descriptor_name":"Viral Nonstructural Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018938","descriptor_name":"Caco-2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043583","descriptor_name":"Nucleoside-Triphosphatase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047028","descriptor_name":"Macrocyclic Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047028","descriptor_name":"Macrocyclic Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D047908","descriptor_name":"Intracellular Signaling Peptides and Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053487","descriptor_name":"DEAD-box RNA Helicases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2008.07.088","doi":"https://doi.org/10.1016/j.bmcl.2008.07.088","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2008.07.088","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:18678486","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18678486","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W2545228","https://openalex.org/W233628489","https://openalex.org/W1995761356","https://openalex.org/W1995778111","https://openalex.org/W1999767209","https://openalex.org/W2001138984","https://openalex.org/W2018050393","https://openalex.org/W2023563124","https://openalex.org/W2027545702","https://openalex.org/W2041273833","https://openalex.org/W2042415731","https://openalex.org/W2042719665","https://openalex.org/W2068168535","https://openalex.org/W2099272027","https://openalex.org/W2108836992","https://openalex.org/W2124816133","https://openalex.org/W2129743974","https://openalex.org/W2151749579","https://openalex.org/W2169406601","https://openalex.org/W2333452860","https://openalex.org/W2951225396"],"related_works":["https://openalex.org/W2912280012","https://openalex.org/W177274442","https://openalex.org/W2159414436","https://openalex.org/W1999767209","https://openalex.org/W8174760","https://openalex.org/W2074600667","https://openalex.org/W308018551","https://openalex.org/W2158177781","https://openalex.org/W2135053008","https://openalex.org/W2033799201"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":16}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}